4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-23-006394
Options or other derivatives
- Chief Business Officer acquired 225,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hannah Brendan Chief Business Officer | 2023-02-01 | Grant or award · Employee Stock Option (right to buy) | +225,000 | 225,000 | D: show line 1 in the form |
Loading xslF345X03/doc4.xml…